Table 1 Study population characteristics. Presented in amounts (percentages of total) or median value (interquartile range)
Population Characteristics | All patients (n = 588) | No aAKI at 7 days (n = 494) | AKI at 7 days (n = 94) | p-value |
|---|---|---|---|---|
Female sex, n (%) | 288 (49.0%) | 256 (43.5%) | 32 (34.0%) | 0.002 |
Age, years (IQR) | 73 (61–82) | 73 (59–82) | 75 (67–84) | 0.007 |
*CHF, n (%) | 111 (18.9%) | 86 (17.5%) | 25 (26.6%) | 0.039 |
*COPD, n (%) | 110 (18.7%) | 92 (18.6%) | 18 (19.4%) | 0.840 |
*Cancer n (%) | 164 (27.9%) | 133 (26.9%) | 31 (33.3%) | 0.198 |
Diabetes Mellitus, n (%) | 114 (19.4%) | 88 (17.8%) | 26 (27.7%) | 0.027 |
Renal Disease, n (%) | 45 (7.7%) | 33 (6.7%) | 12 (12.8%) | 0.292 |
*Immunodeficiency, n (%) | 31 (5.3%) | 26 (5.3%) | 5 (5.4%) | 0.770 |
**Limitation of care, n (%) | 149 (25.3%) | 110 (22.4%) | 39 (41.5%) | < 0.001 |
Severe Sepsis, n (%) | 316 (54.1%) | 231 (47.1%) | 85 (91.4%) | < 0.001 |
Septic Shock, n (%) | 21 (3.7%) | 6 (1.2%) | 15 (17.7%) | < 0.001 |
Diagnosis | 0.141 | |||
Pneumonia, n (%) | 197 (33.5%) | 169 (34.2%) | 28 (29.8%) | N/A |
Urinary Tract Infection, n (%) | 129 (21.9%) | 104 (21.1%) | 25 (26.6%) | N/A |
Soft-tissue Infection, n (%) | 58 (9.9%) | 45 (9.1%) | 13 (13.8%) | N/A |
bOther, n (%) | 155 (26.4%) | 134 (27.1%) | 21 (22.3%) | N/A |
No confirmed infection, n (%) | 49 (8.3%) | 42 (8.5%) | 7 (7.5%) | N/A |
ceGFR, mL/min/kg/1.73m2 (IQR) | 66 (46–88) | 73 (53–91) | 34 (25–48) | < 0.001 |
SCr, umol/L (IQR) | 88 (68–120) | 80 (65–103) | 155 (119–212) | < 0.001 |
penKid, pmol/L (IQR) | 77.9 (56.9–119.7) | 73.9 (53.4–101.2) | 129.3 (92.2–177.5) | < 0.001 |